Position in FTRE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,073,692
+$2,183,041 QoQ
Shares Held
176,649
+86.8% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 334 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. FTRE ranks #40 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in FTRE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,073,692 | 176,649 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $890,651 | 94,549 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,475,892 | 85,559 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $799,613 | 94,966 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $471,014 | 95,347 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $860,398 | 113,960 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,917,872 | 102,835 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $1,819,520 | 90,976 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,195,872 | 94,082 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,967,958 | 98,853 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $3,539,348 | 101,414 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $2,925,185 | 102,315 | Shares | Defined | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||